Lifeboat Foundation

This Week in Science: The First Privately Backed Moon Mission, Using Gene Therapy to Reverse Aging, Artificial Veins and Arteries, and More.

Go here for a clickable image: http://futurism.com/images/this-week-in-science-october-4th-11th-2015/?src=home

Sources
Detecting All Viruses:http://futurism.com/5srzA
Water on Pluto: http://futurism.com/aO2av
Kidney Tissue from Stem Cells: http://futurism.com/DLDON
Converting Algae Blooms into Electrodes: http://futurism.com/w9ez
Fixing Holes in Heart: http://futurism.com/a13Jd
Reversing Aging: http://futurism.com/TjaTL
Private Moon Mission: http://futurism.com/9V626
Artificial Veins: http://futurism.com/rKNzH

Read more

Liz Parrish is the Founder and CEO of BioViva Sciences USA Inc. BioViva is committed to extending healthy lifespans using gene therapy. Liz is known as “the woman who wants to genetically engineer you,” she is a humanitarian, entrepreneur and innovator and a leading voice for genetic cures. As a strong proponent of progress and education for the advancement of gene therapy, she serves as a motivational speaker to the public at large for the life sciences. She is actively involved in international educational media outreach and sits on the board of the International Longevity Alliance (ILA). She is an affiliated member of the Complex Biological Systems Alliance (CBSA) whose mission is to further scientific understanding of biological complexity and the nature and origins of human disease. She is the founder of BioTrove Investments LLC and the BioTrove Podcasts which is committed to offering a meaningful way for people to learn about and fund research in regenerative medicine. She is also the Secretary of the American Longevity Alliance (ALA) a 501©(3) nonprofit trade association that brings together individuals, companies, and organizations who work in advancing the emerging field of cellular & regenerative medicine with the aim to get governments to consider aging a disease. I am not a medical doctor or scientist. I can not answer details of therapy. I would like to discuss my experience of creating BioViva, organizing the gene therapies, and then finally being able to administer it to the first human.

Read more

A 10 year study on yeast at the Buck Institute has uncovered 238 genes that when removed, are linked to longevity.

Read more

Many people may not know it but the most important risk factor for cancer is growing older. Most cancers occur in people over the age of 65.

Many people may not see cancer as an age-related disease, but it’s a major hurdle we’ll have to overcome in the pursuit of longer lives.

Read more

New article on Immortality Bus trip promoting transhumanism with new videos:

It seemed a wild, impossible dream a year ago when I told my wife and young daughters I was going to drive a bus shaped like a coffin across America to raise life extension issues. A week ago, I just finished the second stage of the tour. Soon I’ll begin the third stage from Arizona to Texas, and then across the Bible Belt to Washington DC, where I plan to post a Transhumanist Bill of Rights to the US Capitol building.

If the bus tour seems like a wacky idea–especially for a presidential candidate –it’s because it is. Of course, to transhumanists, a more wacky idea is how most of our nation largely accepts death as a way of life. In the 21st Century, with the amazing science and technology this country has, I don’t believe death needs to be left unconquered. If, as a nation, we would just apply our ingenuity and resources, we could probably conquer death in a decade’s time with modern medicine. That’s precisely the reason why I’m running for president and driving the coffin bus around the country; I want to tell people the important news and get them to support radical technology and longevity science.

Continue reading “Transhumanism Immortality Bus Underway Across America” »

Today, dementia affects over 46 million people worldwide, by 2050 it will affect more than 131 million people.

Global costs of dementia are estimated at $818 billion. As a result, if dementia care were a country, it would be the world’s 18th largest economy.

Dementias are one of the most expensive diseases for the healthcare system as patients require long-term care with daily activities like washing, getting dressed and eating. It has been estimated that the US health care would save an astonishing 40 billion dollars annually if the age of onset for Alzheimer’s disease was delayed by just 5 years. The estimated annual cost of dementia worldwide is 818 billion dollars, more than the current US defence budget. By 2018 the cost may reach a trillion dollars. Remarkably, if dementia were a country, it would be the 18th largest economy on earth.

Read more

An article written by Dr Michael Fossel talking about telomerase therapy for Alzheimer’s and the work Bioviva and Telocyte are doing to beat this horrific condition.

Reversing Alzheimer’s by Lengthening Telomeres.

There are telomere lengthening compounds available right now for use in research labs. They are not currently available for human use. A group of scientists wants to test these compounds on aging humans now to see if the telomere lengthening effects will induce meaningful age reversal effects.

Telomeres in our cells shorten as we grow older and create cellular havoc that predisposes us to multiple age-related pathologies. These experimental enzymes promote telomere lengthening and in the process offer an intriguing opportunity to circumvent biological aging processes.

Continue reading “Alzheimer’s Cure” »

[From CNN]

Human ‘mini brains’ grown in labs may help solve cancer, autism, Alzheimer’s

Story highlights

• Ohio State biomedical research team grows nearly complete human ‘mini brain’
• Brain organoids can be used to learn more about diseases like cancer, Alzheimer’s and Parkinson’s
• Brain organoids could yield autism breakthrough within 10 years, researcher says

By Thom Patterson | Video Source: CNN
Read the full story CNN…

He is working with Dr Maria Blasco of the CNIO in Madrid to bring telomerase therapy to the USA. Their approach is similar to Bioviva where targeting the microglial cells with telomerase inducing gene therapy should in theory reverse the condition. Best of luck to Telocyte!

Telocyte | HomePage.

Read more